RecruitingNCT02282748

Swiss Longitudinal Cohort

Sponsor

Hypertension Excellence Centre Lucerne

Enrollment

1,000 participants

Start Date

Oct 1, 2014

Study Type

OBSERVATIONAL

Conditions

Cardiovascular Risk Factors

Summary

The planned research project is a prospective population-based cohort study, similar to the well-known Framingham study in the United States. So far, there is no similar research project in Switzerland. It is planned to examine of three Swiss municipalities. Recruitment in a first Swiss municipality (Lostallo/Cama GR) started 2014 and ended in 2019. Overall, 496 participants were recruited in this municipality. The five-year follow-up in this municipality started in 2019. It is planned to start recruitment in a second Swiss municipality (Uznach SG) in 2020. The examinations embrace a broad spectrum of measurements (for details the investigators refer to the published study protocol).

Eligibility

Min Age: 6 Years

Inclusion Criteria4

Resident of Cama GR, Lostallo GR, or Uznach SG
Age ≥6 years (no upper age limit), for voluntary blood sample ≥18 years
Willing to participate in long-term study
Written informed consent (in participants ≥6 years and <18 years signed by parents)

Interested in this trial?

Get notified about updates and connect with the research team.